Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 31, 2013. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) in the company's American Depositary Shares (ADSs).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of insider trading activity rather than a financial performance report.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document details specific share transactions by a PDMR:
- Mr. W C Louv exercised options over 2,276 ADSs granted on October 28, 2003, at $43.92 per ADS, and sold them at $51.137 per ADS.
- Mr. W C Louv exercised options over 22,724 ADSs granted on October 28, 2003, at $43.92 per ADS, and sold them at $51.15 per ADS.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The content is strictly limited to the notification of the aforementioned share option exercises and sales.
Investor Verification Checklist
- Verify the total number of ADSs sold by Mr. W C Louv (25,000 total) against the company's insider trading logs.
- Confirm the exercise price ($43.92) and sale prices ($51.137 and $51.15) match market data for July 31, 2013.
- Check subsequent filings for any additional disclosures regarding Mr. Louv's remaining holdings.